Loading clinical trials...
Loading clinical trials...
A Human Controlled Infection Study to Establish Safety of Infection With Bordetella Pertussis With Antibiotic Therapy Delayed for up to 6 Weeks
Conditions
Interventions
Bordetella pertussis B1917
Azithromycin Pill
Locations
1
United Kingdom
NIHR Clinical Research Facility
Southampton, Hampshire, United Kingdom
Start Date
December 6, 2022
Primary Completion Date
December 1, 2025
Completion Date
June 1, 2026
Last Updated
April 8, 2025
Lead Sponsor
University of Southampton
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions